General Information of Drug (ID: DM9H5QG)

Drug Name
ADXS-503
Indication
Disease Entry ICD 11 Status REF
Non-small-cell lung cancer 2C25.Y Phase 1/2 [1]
Cross-matching ID
TTD ID
DPN1F0

References

1 ClinicalTrials.gov (NCT03847519) Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer. U.S. National Institutes of Health.